/CA .4, 3

 

thH’L' , 51%;; W \ I -
(“9922 mi "‘27?” W)?“ ‘ C A 0’ l
/ $1M, ma APPROVED i
/&‘r ,

 

nical Case Report

(For Collection of Cancerous Tissue)

UUID:4D154Aae-FBAE-nssc-sass-2941ntsAsu1s
TcaA-Ca-AlHK-BlA-PR Re acted

II lllIllllllllllllllllllll“Illlllllllllllllllllllllllll
|

D.

 

|
”NIH” ||||||||||||||||||
IIIHII H | |||||||||||||

II
N ll |
|| ||||||I|||||| ll |||l|I|||| I “II“ I II“ I informed Consent}

 

I personally informed this patient that a specimen(sl would be collected to be used for research

purposes. I reviewed the . _ . "‘_"".‘
with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

our institution. .

_..__...

Name of Physician or Study Coordinator Signature Date

 

 

IClinical Informatiord

 

man

1': Married
Gender El Divorced D Widow Blood Pressure Heart Rate

El Male emale 4 "" "‘

 

 

   

   

"mﬁf—ﬁ; E?“ 1ﬁVFHIS'lZ'OIuﬁtDETRESENT ILENESS’?‘ ,. 5.217" "'
Chief Com lainu: A i , \ .

p lW .5 run; W WV
Symptom“ (Pvui'xki‘ W L WV @me M} Lei: ‘ lml‘ llama/(“$5 “’10 _

Clinical Findings: 5 i _ \
Ltd-mm ~ MW [LA/s 4K , Jwvl
H mi Wat/ea mg: mil/slang) m

:1 60-70 Symptomatic, in bed less than 50% of day
:1 20-30 Bed Ridden

 

 

 

 

Performance Scale (Kamofsky Score):
a 100 Asymptomatic a 80-90 Symptomatic but Fully Ambulatory
D 40-50 §ymptomatic, in bed more than 50% of day._but not bed ridden

 

 

 

MEDIGA"

   

, ;--:». P‘AST MEDICAL HISTORY: ' . - 1 -'~.
Disorder Date Treatment Status

 

 

. w“

     

  

 

 

 

 

 

 

 

 

 

,. . . L . , ' ‘ ’ NEIGYNZIIISTOszs-t at
Menopausal Status Date of First Menses # of P
E] Pre-menopausal ' ’b»; M ,
eri-Menopausal Date of Last Mensa # of Live Blrths
El Post-menopausal 6.01.4 réf.
Birth Control: a Condom :1 Oral Contraceptive" u lUD u Hormone Replacement
D Other: N0 . Therapy:

 

 

Envlronmental Hazards:

H
Duration

Alcohol Consum
TYPE Duration

Use
Duration

Test
HIV D Positive: ' El Positive:
H B D Positive: ‘ E] Positive:
H C El [:1 Positive: 1 ‘ El Positive:
AFP E) El Positive: D Positive:
Other:

a Negative D Positive: ,, Negative :1 Positive:

B/T Cell Markers:

 

 

 

" r" " t: DIAGNOSTIC STUDIES 9213' 142:3;1'.‘ £35»
Results
Ultrasound
X-
CT

MRI
B

' GNOSIS’
Clinical
VL‘ CU»
Location of Involved L Nodes Location of
1 we
Clinical
N M Stage: 11.

 

 

Ereatment Informatiod

i'SURGI ' 1 .. “t” .. .1 .
Date of Procedure

.1 .1 . .
w:

Tumor
Detailed Location

Extension of

L Nodes
Location of L Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

 

Collected by:

Preserved by: __

Frozen
Diseased Normal

Time to LN2

Pathology Form

 

Specimen Informatioj

Date. - __Time:

Date: 5 ' ,_Iime:

 

Parafﬁn Block
Diseased Normal

7Q so

Time to Formalin

Normal

to LN2
min

A 'D 0

Tumor
Size Extension of Tumor

X cm

Nodes
# Examined

Distance to NAT
9...

# Metastasized

Distant Metastasis
Detailed

 

 

. CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM* -
Micmscopic Appearance

I.
CELL

Diffuse
Mosaic
Necrosis

Vascular

2. Cellular
'1' .
Glandular cell
Cell Cell swinging-
Kevin S! .
Dennosome “cm
W Gland formation

(3 Otherwise Speciﬁed: I 7 .5 b7, 7

   

2. Cellular Dg’ﬂ'mndaﬁ”;

 

 

 

 

Well Madge”, Poor

 

 

 

' 3

 

 

Nuclear
@.

Histological Diagnosis: W M, .2.

. Comments:_.
“—7):—
”—4
Birdwamlrl’m—

I museum.

 

